The “Volta Ciclista a Catalunya” and GAEM Foundation, a caring tandem Blog Post

The Volta Ciclista a Catalunya associates to GAEM Foundation, creating a caring tandem in the fight to find a cure for Multiple Sclerosis. The exceptional media coverage of “La Volta” –one of the most important races with a long trajectory in the world– will give voice and make visible the need to promote research projects to find a cure for this neurological disease –which affects about 50,000 people in Spain– and improve the quality of life of the patients.

 

Urea-powered nanomotors a promising therapy for bladder cancer Blog Post

The Smart Nano-Bio-Devices group at the Institute for Bioengineering of Catalonia (IBEC) in the Barcelona Science Park have published a paper describing nanomotors that can attack 3D bladder cancer spheroids in vitro. The study reveals that nanomotors are a promising way to specifically target tumor tissues, enhancing the efficacy of cancer treatment and minimizing side effects.

 

Launch of “StarLife”, a new informatics infrastructure to boost biomedical research Blog Post

Today marks the official presentation of “StarLife”, an informatics cluster that is housed at the Barcelona Supercomputing Center. This infrastructure is designed to give impetus and service to biomedical research of excellence and precision medicine. A joint initiative of the Institute for Research in Biomedicine (IRB Barcelona) based in the Barcelona Science Park, the Barcelona Supercomputing Center – Centro Nacional de Supercomputación (BSC-CNS) and the Centre for Genomic Regulation (CRG). StarLife is funded by the Catalan Government –through the ERDF– and ”la Caixa”.

 

Aromics recieves 1 M€ from the European Union to boost its drug against the asbestos-related hallmark cancer Blog Post

Aromics, a biotech company located at the Barcelona Science Park (PCB), has been awarded with 1,085.659€ from the European Union – through the SME instrument of the Horizon 2020 (H2020-EIC-SMEInst-2018-2020-Phase 2)– for the development of the BERMES project, whose objective is the completion of the regulatory preclinics of NAX035, an innovative therapy for the treatment of malignant mesothelioma, an aggressive and highly refractory tumor directly related to asbestos exposure.

 

Joan J. Guinovart awarded with the Royal Academy of Pharmacy of Catalonia Prize Blog Post

Joan J. Guinovart was awarded XXII Prize from the Royal Academy of Pharmacy of Catalonia in recognition of his significant contribution to the field of pharmacy in Catalonia, as well as in Spain and the rest of the world. Guinovart served as the first director of the Institute for Research in Biomedicine (IRB Barcelona) and is the group leader of the Metabolic Engineering and Diabetes Therapy lab at the same institute based in PCB.

 

Defective glial cells can push neurons toward Parkinson’s disease Blog Post

Defective versions of human brain cells called astrocytes are linked to the buildup of a toxic protein that is one the hallmarks of Parkinson’s disease. This is one of the main conclusions of a study led by Antonella Consiglio, researcher at the Institute of Biomedicine of the University of Barcelona (IBUB) in the Barcelona Science Park, and the Bellvitge Biomedical Research Institute (IDIBELL), and Àngel Raya, from the Center of Regenerative Medicine in Barcelona (CMR[B]-IDIBELL).

 

Researchers at IRB Barcelona develop a tool to tackle resistance in cancer Blog Post

The lab headed by Modesto Orozco at the Institute for Research in Biomedicine (IRB Barcelona) in the Barcelona Science Park has developed a tool to tackle resistance in cancer. The therapeutic approach has been validated in breast cancer cells in vitro, and the results have been published in the scientific journal Chemical Communications.

 

Biocat Report shows growth in international investment in BioRegion of Catalonia Blog Post

More than 300 professionals from the sector attended the event to present a new edition of the Biocat Report, the benchmark study on the healthcare and life sciences sector in Catalonia. Under de title “Escaling-up the BioRegion of Catalonia”, the Biocat Report highlights the growing attractiveness of the life sciences and health sector for international investment –linked to the positioning of the BioRegion as a European hub in health research–, the increase in the number of companies and the occupation of sector, as well as the advance of innovation in health towards social impact. Biocat, the organization that coordinates and promotes the life sciences sector in Catalonia, has its headquarters in the Barcelona Science Park.